SpecialityChief Executive Officer and Co-Founder, Halia Therapeutics

Biography:Dr. David J. Bearss is a seasoned drug developer with over 25 years of experience in both academic and industry settings. He specializes in small molecule drug development, employing structure-based drug design and computational approaches for drug discovery. Dr. Bearss has successfully discovered 16 compounds with FDA-accepted INDs and contributed to the development of two approved drugs. As a co-founder of eight biotech companies, Dr. Bearss holds over 75 patents and has authored 85 peer-reviewed research publications. His entrepreneurial and scientific contributions have earned him several awards, including the Utah Governor's Medal of Science.